BD Biosciences Announces Agreement with Dynomics to Collaborate on Novel Cancer Diagnostic Technology
31-Mar-2006 -
BD Biosciences, a segment of BD, announced a licensing and research agreement with Dynomics BV in the fields of leukemia and lymphoma. Under terms of the agreement, BD has an exclusive worldwide license to specific intellectual property related to the flow cytometry detection of fusion proteins. ...
BD
chromosomes
flow cytometry
+6